Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enzo Biochem, Inc. Common Stock ($0.01 Par Value) (NY:ENZ)

0.3400 -0.0300 (-8.11%)
Official Closing Price Updated: 7:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

< Previous 1 2 3 Next >
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Monday's pre-market session: top gainers and losers
Wondering what's happening in Monday's pre-market session? Find an overview in this article. 
Via Chartmill
Why Xos Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
ENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024
Enzo Biochem just reported results for the third quarter of 2024. 
Via InvestorPlace
ENZ Stock Earnings: Enzo Biochem Reported Results for Q1 2024
Enzo Biochem just reported results for the first quarter of 2024. 
Via InvestorPlace
Wondering what's happening in today's after-hours session?
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
From Enzo Biochem, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
From Enzo Biochem, Inc.
Via GlobeNewswire
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter. 
Via Benzinga
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
From Enzo Biochem, Inc.
Via GlobeNewswire
HEICO, EMCOR Group And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
From Enzo Biochem, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
From Enzo Biochem, Inc.
Via GlobeNewswire
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
From Enzo Biochem, Inc.
Via GlobeNewswire
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Expion360 Holdings Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another dive into the biggest pre-market stock movers as we check out the most recent news for Tuesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
From Enzo Biochem, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results
From Enzo Biochem, Inc.
Via GlobeNewswire
Federman & Sherwood Investigates Enzo Biochem for Data Breach
From Federman & Sherwood
Via Business Wire
Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale
From Enzo Biochem, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.